Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

INTS9 Inhibitors

INTS9 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the INTS9 protein, a subunit of the Integrator complex. The Integrator complex is a multi-subunit protein assembly that plays a critical role in the regulation of gene expression, particularly by interacting with RNA polymerase II during transcription. INTS9, as one of the subunits of this complex, is involved in the processing of small nuclear RNAs (snRNAs) and the termination of non-coding transcription. By inhibiting INTS9, these compounds can alter the normal activity of the Integrator complex, leading to disruptions in RNA processing and transcription regulation. The specificity of INTS9 inhibitors allows them to interfere with distinct steps in the transcriptional process, making them valuable tools for studying gene expression and RNA biology.

Inhibitors of INTS9 are often utilized in molecular biology to dissect the roles of individual subunits of the Integrator complex. By selectively inhibiting INTS9, researchers can investigate how its suppression affects RNA processing pathways and gene regulation at a transcriptional level. These inhibitors may be synthesized with varying levels of specificity and potency, depending on the structural composition and binding affinity for the INTS9 protein. Through structural biology and biochemical studies, it is possible to understand the mechanisms by which these inhibitors interact with INTS9 and their downstream effects on gene transcription. In this way, INTS9 inhibitors serve as powerful molecular tools to probe the intricate mechanisms of RNA transcription and processing.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Inhibits RNA Polymerase II (Pol II), potentially affecting snRNA processing and integrator complex function.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Affects transcription elongation by Pol II, potentially influencing integrator complex functions.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$317.00
(2)

Cyclin-dependent kinase inhibitor, could affect transcription regulation and impact INTS9.

RGFP966

1357389-11-7sc-507300
5 mg
$115.00
(0)

Selective inhibitor of histone deacetylase 3 (HDAC3), may indirectly affect transcription and INTS9 activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

HDAC inhibitor, potentially influencing chromatin structure and integrator complex function.

Panobinostat

404950-80-7sc-208148
10 mg
$200.00
9
(1)

Broad HDAC inhibitor, might affect chromatin structure and transcription, indirectly impacting INTS9.

CPI-203

1446144-04-2sc-501599
1 mg
$170.00
(0)

Inhibits CREB binding protein (CBP)/p300, potentially impacting transcription regulation and INTS9 function.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$231.00
$863.00
1
(0)

Inhibits BET bromodomain proteins, could affect transcription and thus INTS9 activity.

THZ1

1604810-83-4sc-507542
1 mg
$95.00
(0)

CDK7 inhibitor, affecting transcription initiation and elongation, may influence INTS9.

Pladienolide B

445493-23-2sc-391691
sc-391691B
sc-391691A
sc-391691C
sc-391691D
sc-391691E
0.5 mg
10 mg
20 mg
50 mg
100 mg
5 mg
$299.00
$5699.00
$11099.00
$25500.00
$66300.00
$2875.00
63
(2)

Inhibits the spliceosome, potentially affecting processes relevant to INTS9.